Carregant...

Recombinant tissue plasminogen activator for the treatment of acute ischemic stroke

The use of recombinant tissue plasminogen activator (rtPA) has been the standard of care for treatment of acute ischemic stroke for several years. Studies evaluating the efficacy, safety, and optimal timing of rtPA use are ongoing. Recently, results of new studies led to expansion of the short timef...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Roth, Jennifer M.
Format: Artigo
Idioma:Inglês
Publicat: Baylor Health Care System 2011
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3124916/
https://ncbi.nlm.nih.gov/pubmed/21738304
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!